Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Single and Multiple Doses of Linagliptin Tablets in Patients With Different Degrees of Renal Impairment in Comparison to Subjects With Normal Renal Function
Clinical trial NCT02191228 · COMPLETED
Trial details
- NCT number
- NCT02191228
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2010-02-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.